Treatment & Doctors - Page 10
Bevacizumab May Be Next Standard of Care for Mesothelioma
- by Tim Povtak
- Treatment & Doctors
- Jun 5, 2015
Standard of care treatment for malignant pleural mesothelioma may be changing soon, based on discussions last week at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago.
Read More
Surgery Extends Survival for Pleural Mesothelioma Patients
- by Tim Povtak
- Treatment & Doctors
- Jun 3, 2015
Thoracic surgeon and mesothelioma specialist Dr. Andrea Wolf likes to use the analogy that you don’t need a randomized trial to know that skydivers with a parachute generally will fare…
Read More
Study Finds UK Must Improve Mesothelioma Care
- by Tim Povtak
- Treatment & Doctors
- May 15, 2015
The United Kingdom needs a more universal, multidisciplinary approach to the treatment of malignant pleural mesothelioma to improve survival times and overcome the no-hope attitude that too often surrounds…
Read More
Fish Oil Supplements Could Harm Cancer Patients
- by Tim Povtak
- Treatment & Doctors
- May 14, 2015
Taking common fish oil supplements or even eating a particular fish may reduce the effectiveness of chemotherapy for cancer patients, including those with malignant mesothelioma, according to a new study.
Read More
Powerful Skin Cancer Drug Stops Mesothelioma Tumor Growth
- by Tim Povtak
- Treatment & Doctors
- Apr 27, 2015
A groundbreaking immunotherapy drug that effectively treats skin cancer stopped tumor growth in 76 percent of patients diagnosed with malignant pleural mesothelioma, a recent study shows. Researchers at the…
Read More
Mesothelioma Patients Live Longer After Aggressive Cancer Surgery
- by Tim Povtak
- Treatment & Doctors
- Apr 23, 2015
Aggressive pleurectomy/decortication surgery, while often recommended, will cause a significant decrease in pulmonary function with early-stage mesothelioma patients whose symptoms were previously minimal. More symptomatic patients with advanced disease will…
Read More
FDA Approves New Use for Immunotherapy Drug in Mesothelioma Treatment
- by Tim Povtak
- Treatment & Doctors
- Apr 7, 2015
The U.S. Food and Drug Administration (FDA) granted orphan drug designation last week to the immunotherapy vaccine CRS-207, moving it one step closer to changing the way malignant pleural mesothelioma…
Read More
New Mesothelioma Treatment Options Are Emerging for Patients
- by Tim Povtak
- Treatment & Doctors
- Apr 2, 2015
Although no definitive cure is in sight, the treatment of malignant pleural mesothelioma has entered a promising, much-anticipated phase that goes beyond the multimodal approach that has been the…
Read More
New Lung Cancer Drug Opdivo May Hold Hope for Mesothelioma Patients
- by Tim Povtak
- Treatment & Doctors
- Mar 16, 2015
Federal approval of the highly-touted immunotherapy drug Opdivo for advanced squamous non-small cell lung cancer may signal good news for malignant pleural mesothelioma patients. The U.S. Food and Drug…
Read More
UK Study Shows Promise for Epithelioid Mesothelioma Patients
- by Tim Povtak
- Treatment & Doctors
- Mar 12, 2015
More than 30 percent of patients with epithelioid mesothelioma, the most common cellular strain of this cancer. lived for five years or more after a multidisciplinary treatment approach in England,…
Read More
